Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Caredx Inc (CDNA)

Caredx Inc (CDNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Caredx Inc 8000 Marina Boulevard 4th Floor Brisbane CA 94005 USA

www.caredx.com Employees: 650 P: 415-287-2300 F: 415-287-2450

Sector:

Medical

Description:

CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California.

Key Statistics

Overview:

Market Capitalization, $K 1,057,977
Enterprise Value, $K 943,287
Shares Outstanding, K 51,433
Annual Sales, $ 333,790 K
Annual Net Income, $ 52,550 K
Last Quarter Sales, $ 100,060 K
Last Quarter Net Income, $ 1,680 K
EBIT, $ -46,350 K
EBITDA, $ -25,970 K
60-Month Beta 2.49
% of Insider Shareholders 4.40%
Float, K 49,170
% Float 95.60%
Short Interest 6,260
Short Float 12.17%
Short Volume Ratio 0.39

Growth:

1-Year Return -19.47%
3-Year Return 43.55%
5-Year Return -75.92%
5-Year Revenue Growth 162.68%
5-Year Earnings Growth 278.85%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.28 on 11/04/25
Next Earnings Date 02/25/26
Earnings Per Share ttm 1.19
EPS Growth vs. Prev Qtr 118.75%
EPS Growth vs. Prev Year 121.43%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

CDNA Ratios

Ratio
Price/Earnings ttm 14.40
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 20.15%
Return-on-Assets % 15.15%
Profit Margin % 15.74%
Debt/Equity 0.00
Price/Sales 3.33
Price/Cash Flow 12.60
Price/Book 2.83
Book Value/Share 6.05
Interest Coverage -1.48
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar